NCT03515538 2024-11-04
PREVLAR
EpicentRx, Inc.
Phase 2 Completed
EpicentRx, Inc.
BioMimetix JV, LLC
Masonic Cancer Center, University of Minnesota
Swedish Orphan Biovitrum
Swedish Orphan Biovitrum
Roswell Park Cancer Institute
University College, London